TREML2/TLT-2, His, Human
| $410.00 | |
| Z05924-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $410.00 | |
| Z05924-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 28.2 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 73-80 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
The purity of TREML2/TLT-2, His, Human is greater than 95% as determined by SEC-HPLC. »
TREML2/TLT-2, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | As an important family member of triggering receptor expressed on myeloid cells (TREM), TREM-like transcript 2 gene (TREML2) locates on human chromosome 6p21.1, a newly-identified hot zone for AD susceptibility, and encodes atransmembrane immune receptor. Emerging evidence implied a potential role of TREML2 in the susceptibility and pathogenesis of AD. |
| Synonyms | TLT-2; C6orf76; dJ238O23.1; FLJ13693; MGC149715; MGC149716; TREML2; UNQ6268/PRO20473 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.